Page 17 - 《中国药房》2026年6期
P. 17

Interventional  Surgery,Society  for  Vascular  Medicine,  et  al.  Successful  treatment  of  intracardiac  thrombosis  in
              and Society for Vascular Surgery: developed in collabora‐  the presence of fulminant myocarditis requiring ECMO as‐
              tion with the American Academy of Neurology and Society   sociated  with  COVID-19[J].  J  Heart  Lung  Transplant,
              of  Cardiovascular  Computed  Tomography[J].  Catheter   2022,41(6):849-851.
              Cardiovasc Interv,2013,81(1):E76-E123.         [47]  FERRY  J,YOUSSEF  S,WU  P,et  al.  Heparin-induced
          [36]  SAW J,BAJZER C,CASSERLY I P,et al. Evaluating the   thrombocytopenia  presenting  as  splenic  hemorrhage  fol‐
              optimal activated clotting time during carotid artery stent-  lowing cardiac surgery:a case report[J]. Thromb J,2021,
              ing[J]. Am J Cardiol,2006,97(11):1657-1660.         19(1):4.
          [37]  ARMSTRONG  E  J,LAIRD  J  R.  Bivalirudin  for  carotid   [48]  NIEDEGGEN A,LEJCZYK J,KRONER S,et al. Treat‐
              artery stenting:a new approach on the HORIZON(s)[J].   ment  of  intracardiac  thrombi  with  argatroban[J].  Acute
              Circ Cardiovasc Interv,2013,6(2):125-127.           Card Care,2008,10(4):221-226.
          [38]  STABILE E,SORROPAGO G,TESORIO T,et al. Hepa‐  [49]  ISHIZUKA S,NAKAYAMA K,YAGAWA K,et al. Case
              rin  versus  bivalirudin  for  carotid  artery  stenting  using   of  lupus  peritonitis  with  thrombus  in  the  right  atrium[J].
              proximal  endovascular  clamping  for  neuroprotection:re‐  Nihon Jinzo Gakkai Shi,2010,52(2):154-159.
              sults from a prospective randomized study[J]. J Vasc Surg,  [50]  HEID J,GREINACHER A,KATUS H A,et al. Idiopathic
              2010,52(6):1505-1510.                               catastrophic thrombosis with happy ending[J]. BMJ Case
          [39]  GEISBÜSCH P,KATZEN B T,PEÑA C,et al. Bivaliru‐    Rep,2017,2017:bcr2017221194.
              din used as alternative anticoagulant in carotid artery stent-  [51]  KIM Y,CHOI  D  C,ZAIDI A  N.  Extensive  intracardiac
              ing:a  single  center  observational  study[J].  J  Interv  Car‐  and  deep  venous  thromboses  in  a  young  woman  with
              diol,2012,25(2):197-202.                            heparin-induced thrombocytopenia and May-Thurner syn‐
          [40]  LIN P H,BUSH R L,PEDEN E K,et al. Carotid artery   drome[J]. Case Rep Hematol,2017,2017:8530476.
              stenting with neuroprotection:assessing the learning curve   [52]  AHMED A,AL-MONDHIRY H,MILLING T J Jr,et al.
              and  treatment  outcome[J].  Am  J  Surg,2005,190(6):  Heparin-induced  thrombocytopenia  associated  with  mas‐
              850-857.                                            sive  intracardiac  thrombosis:a  case  report[J].  Case  Rep
          [41]  WAYANGANKAR S A,ABU-FADEL M S,ARONOW H            Hematol,2012,2012:257023.
              D,et al. Hemorrhagic and ischemic outcomes after bivali‐  [53]  SANDOVAL E,ASCASO M,QUINTANA E,et al. An in‐
              rudin  versus  unfractionated  heparin  during  carotid  artery   frequent  complication  of  a  not  so  infrequent  disease:hit
              stenting:a  propensity  score  analysis  from  the  NCDR[J].   by HIT[J]. Asian Cardiovasc Thorac Ann,2019,27(2):
              Circ Cardiovasc Interv,2013,6(2):131-138.           124-126.
          [42]  COGAR B D,WAYANGANKAR S A,ABU-FADEL M,       [54]  TERRY C M,HE Y X,CHEUNG A K. Rivaroxaban im‐
              et al. Clinical safety of bivalirudin in patients undergoing   proves  patency  and  decreases  inflammation  in  a  mouse
              carotid  stenting[J].  J  Invasive  Cardiol,2012,24(5):  model of catheter thrombosis[J]. Thromb Res,2016,144:
              202-205.                                            106-112.
          [43]  KANIA T A,SHAH S,GUO T,et al. Safety and efficacy   [55]  WILKIESON T J,INGRAM A J,CROWTHER M A,et
              of  bivalirudin  as  a  heparin  alternative  in  patients  under-  al.  Low-intensity  adjusted-dose  warfarin  for  the  preven‐
              going  carotid  artery  stenting[J].  Ann  Vasc  Surg,2026,  tion  of  hemodialysis  catheter  failure:a  randomized,con‐
              122:8-17.                                           trolled trial[J]. Clin J Am Soc Nephrol,2011,6(5):1018-
          [44]  LEWIS B E,RANGEL Y,FAREED J. The first report of   1024.
              successful  carotid  stent  implant  using  argatroban  anti-  [56]  VAN COTT E M,ROBERTS A J,DAGER W E. Labora‐
              coagulation in a patient with heparin-induced thrombocy‐  tory monitoring of parenteral direct thrombin inhibitors[J].
              topenia and thrombosis syndrome:a case report[J]. Angi-  Semin Thromb Hemost,2017,43(3):270-276.
              ology,1998,49(1):61-67.                        [57]  何志婷,史珂慧,刘华,等. 阿加曲班预防半永久中心静
          [45]  DEGIOVANNI A,CARASSIA  C,DE VECCHI  S,et  al.     脉导管血栓形成的疗效研究[J]. 中国血液净化,2014,13
              Atrial thrombosis:not only left,think also about right[J]. J   (9):669-672.
              Clin Ultrasound,2022,50(8):1194-1201.                         (收稿日期:2025-11-10  修回日期:2026-03-05)
          [46]  MEJIA E J,O’CONNOR M J,SAMELSON-JONES B J,                                        (编辑:孙 冰)











          中国药房  2026年第37卷第6期                                                 China Pharmacy  2026 Vol. 37  No. 6    · 699 ·
   12   13   14   15   16   17   18   19   20   21   22